FDA to Pay Bonuses for Faster Drug Reviews, Sparking Debate
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Understanding the pros of zero based budgeting can empower you to take control of your finances. Learn how this approach can benefit your budgeting efforts.
15,688 articlesThe FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Two popular small-cap growth ETFs—ISCG and VBK—aim to capture the fast-growing corner of the U.S. market. This guide ...
Investors are watching alarm.com with a focus on how 2026 earnings will unfold. This guide explains the key drivers, ...
A large fund sold about $17 million in ZoomInfo shares while the company posted slim revenue growth. This article bre...
As Bank Montreal prepares to report its Q2 2026 results, investors want clarity on growth, credit quality, and return...
Nvidia has stumbled from its record highs in 2026, but a dip can offer opportunity—if you know how to evaluate the od...
Is IonQ stock overvalued right? This in-depth guide breaks down the technology, market timing, and financials to help...
A notable fund boosted its Hexcel stake to roughly 23% of its portfolio after a $7.5 million purchase, sending the st...
XRP is making moves today as headlines and on-chain signals collide with market anxiety. This guide breaks down why t...
Small-cap growth ETFs can be a powerful part of a diversified portfolio. This article compares ISCG and SLYG on costs...
Energy Transfer has kicked off the year with impressive momentum and a raised outlook. This article breaks down why t...
Metropolis has surged to a $5 billion valuation after a 2025 funding round, transforming parking networks into a broa...